Education
About Us
Working with TipRanks
Follow Us
Pharmagreen Biotech Inc. (PHBI)
OTHER OTC:PHBI
Total Valuation
Pharmagreen Biotech has a market cap or net worth of $995.47K. The enterprise value is $838.78K.
Market Cap$995.47K
Enterprise Value$838.78K
Share Statistics
Pharmagreen Biotech has 663,645,750 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding663,645,750
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Pharmagreen Biotech’s return on equity (ROE) is 0.33 and return on invested capital (ROIC) is 8.93%.
Return on Equity (ROE)0.33
Return on Assets (ROA)-10.28
Return on Invested Capital (ROIC)8.93%
Return on Capital Employed (ROCE)0.08
Revenue Per Employee3.41K
Profits Per Employee-1.00M
Employee Count1
Asset Turnover0.03
Inventory Turnover0.21
Valuation Ratios
The current PE Ratio of Pharmagreen Biotech is -2.76. Pharmagreen Biotech’s PEG ratio is -0.11.
PE Ratio-2.76
PS Ratio272.46
PB Ratio-0.90
Price to Fair Value-0.90
Price to FCF-98.62
Price to Operating Cash Flow-98.62
PEG Ratio-0.11
Income Statement
In the last 12 months, Pharmagreen Biotech had revenue of 3.41K and earned -1.00M in profits. Earnings per share was 0.00.
Revenue3.41K
Gross Profit1.74K
Operating Income-248.18K
Pretax Income-1.00M
Net Income-1.00M
EBITDA0.00
Earnings Per Share (EPS)0.00
Cash Flow
In the last 12 months, operating cash flow was -32.33K and capital expenditures 0.00, giving a free cash flow of -32.98K billion.
Operating Cash Flow-32.33K
Free Cash Flow-32.98K
Free Cash Flow per Share>-0.01
Dividends & Yields
Pharmagreen Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.18
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)1.32M
Important Dates
Pharmagreen Biotech upcoming earnings date is Dec 19, 2025, TBA Not Confirmed.
Last Earnings DateSep 2, 2024
Next Earnings DateDec 19, 2025
Ex-Dividend Date―
Financial Position
Pharmagreen Biotech as a current ratio of <0.01, with Debt / Equity ratio of -14.99%
Current Ratio<0.01
Quick Ratio<0.01
Debt to Market Cap0.13
Net Debt to EBITDA0.00
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pharmagreen Biotech has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pharmagreen Biotech EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -111.29.
EV to Sales916.66
EV to EBITDA0.00
EV to Free Cash Flow-111.29
EV to Operating Cash Flow-111.29
Balance Sheet
Pharmagreen Biotech has $906.00 in cash and marketable securities with $352.41K in debt, giving a net cash position of $351.50K billion.
Cash & Marketable Securities$906.00
Total Debt$352.41K
Net Cash$351.50K
Net Cash Per Share<$0.01
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 44.84%, with operating margin of -7278.06%, and net profit margin of -29454.52%.
Gross Margin44.84%
Operating Margin-7278.06%
Pretax Margin-29455.54%
Net Profit Margin-29454.52%
EBITDA Margin0.00%
EBIT Margin-7278.06%
Analyst Forecast
The average price target for Pharmagreen Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-29.10%
EPS Growth Forecast78.57%